Cover Image

A Genetic Association Study of MTHFR C677T Polymorphism with Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis

Soheil Azizi, Amir Shamshirian, Reza Alizadeh-Navaei, Hamed Jafarpour, Zatollah Asemi, Omid Reza Tamtaji, Mohammad Sadegh Vaziri, Reza Homayounfar, Arash Rezaei Shahmirzadi, Reza Alipoor

Methylenetetrahydrofolate reductase (MTHFR) is an enzyme that plays a crucial role as a methyl-group donor in demethylation of homocysteine. The aim of this systematic review and meta-analysis was to study the relationship between MTHFR gene polymorphism and metabolic syndrome (MS). We used search engines and databases such as Science Direct, Google Scholar, Embase, Cochrane Library, and PubMed to identify eligible studies up to 2018. The articles were studied based on keywords including MTHFR, mutation, variant, and polymorphism in combination with MS. Data was analyzed using Comprehensive Meta-Analysis version 2.2.064 software. After extracting the data from seven articles, the total number of subjects was 1280 in the patient group and 1374 in the control group. The odds ratio was estimated to be 1.078 for the allele model of T vs. C (95% confidence interval [CI]: 1.626-0.715), 1.157 for the allele model of CC vs. CT (95% CI: 0.829-1.615), 1.020 for the allele model of CT + TT vs. CC (95% CI: 1.611-0.646) and 0.799 for the allele model of TT vs. CC + CT (95% CI: 1.185-0.539). As well, the results showed no statistically significant correlation between polymorphism genotypes of the MTHFR gene and MS (P<0.05). In general, this study showed that the presence of C677T polymorphism in the MTHFR gene has no effect on the incidence of MS. [GMJ.2019;8:e1472]

MTHFR; Metabolic Syndrome; Polymorphism; Variant; Meta-Analysis; Methylenetetrahydrofolate Reductase

Maroto-Sánchez B, Lopez-Torres O, Palacios G, González-Gross M. What do we know about homocysteine and exercise? A review from the literature.

Clin Chem Lab Med. 2016;54(10):1561-77.

Frosst P, Blom H, Milos R, Goyette P, Sheppard CA, Matthews R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-3.

https://doi.org/10.1038/ng0595-111

PMid:7647779

Outinen PA, Patricia C, SARGE KD, MAEDA N, HIRSH J, RIBAU J, et al. Characterization of the stress-inducing effects of homocysteine. Biochem J. 1998;332(1):213-21.

https://doi.org/10.1042/bj3320213

PMid:9576870 PMCid:PMC1219470

van Guldener C, Stehouwer CD, editors. Diabetes mellitus and hyperhomocysteinemia. Seminars in vascular medicine; 2002: Copyright© 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Becker A, Smulders Y, Van Guldener C, Stehouwer C. Epidemiology of homocysteine as a risk factor in diabetes. Metab Syndr Relat Disord. 2003;1(2):105-20.

https://doi.org/10.1089/154041903322294434

PMid:18370632

Li S, Zhu J, Wu L, Peng L, Luo Y, Zhao Y, et al. The association between plasma homocysteine and ambulatory blood pressure variability in patients with untreated hypertension. Clin Chim Acta. 2018;477:32-8.

https://doi.org/10.1016/j.cca.2017.11.042

PMid:29203427

Cai W, Yin L, Yang F, Zhang L, Cheng J. Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essential hypertension. Biomed Rep. 2014;2(6):861-8.

https://doi.org/10.3892/br.2014.357

PMid:25279160 PMCid:PMC4179705

Martos R, Valle M, Morales R, Cañete R, Gavilan MI, Sánchez-Margalet V. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children. Metabolism. 2006;55(1):72-7.

https://doi.org/10.1016/j.metabol.2005.07.008

PMid:16324922

Lenna S, Han R, Trojanowska M. Endoplasmic reticulum stress and endothelial dysfunction. IUBMB life. 2014;66(8):530-7.

https://doi.org/10.1002/iub.1292

PMid:25130181 PMCid:PMC4181710

Giltay E, Hoogeveen E, Elbers J, Gooren L, Asscheman H, Stehouwer C. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis. 1998;139(1):197-8.

Ghogomu S, Ngolle N, Mouliom R, Asa B. Association between the MTHFR C677T gene polymorphism and essential hypertension in South West Cameroon. Genet Mol Res. 2016;15(1):28.

https://doi.org/10.4238/gmr.15017462

PMid:27051013

Zhu B, Wu X, Zhi X, Liu L, Zheng Q, Sun G. Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies. PloS one. 2014;9(7):e102443.

https://doi.org/10.1371/journal.pone.0102443

PMid:25047451 PMCid:PMC4105552

Liew S-C, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. 2015;58(1):1-10.

https://doi.org/10.1016/j.ejmg.2014.10.004

PMid:25449138

Wu S, Han Y, Hu Q, Zhang X, Cui G, Li Z, et al. Effects of common polymorphisms in the MTHFR and ACE genes on diabetic peripheral neuropathy progression: a meta-analysis. Mol Neurobiol. 2017;54(4):2435-44.

https://doi.org/10.1007/s12035-016-9823-4

PMid:26971290

Russo G, Di Benedetto A, Alessi E, Ientile R, Antico A, Nicocia G, et al. Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. J Endocrinol Invest. 2006;29(3):201-7.

https://doi.org/10.1007/BF03345540

PMid:16682831

Roffeei SN, Mohamed Z, Reynolds GP, Said MA, Hatim A, Mohamed EHM, et al. Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics. Pharmacogenomics. 2014;15(4):477-85.

https://doi.org/10.2217/pgs.13.220

PMid:24624915

Tang R, Liu H, Yuan Y, Xie K, Xu P, Liu X, et al. Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma. Oncotarget. 2017;8(21):35403.

https://doi.org/10.18632/oncotarget.15893

PMid:28515345 PMCid:PMC5471064

Chedraui P, Pérez-López F, Escobar G, Espinoza-Caicedo J, Montt-Guevara M, Genazzani A, et al. Polymorphisms of the FTO and MTHFR genes and vascular, inflammatory and metabolic marker levels in postmenopausal women. J Endocrinol Invest. 2016;39(8):885-90.

https://doi.org/10.1007/s40618-016-0443-7

PMid:26902996

Chen A-R, Zhang H-G, Wang Z-P, Fu S-J, Yang P-Q, Ren J-G, et al. C-reactive protein, vitamin B12 and C677T polymorphism of N-5, 10-methylenetetrahydrofolate reductase gene are related to insulin resistance and risk factors for metabolic syndrome in Chinese population. Clin Invest Med. 2010;33(5):290-7.

https://doi.org/10.25011/cim.v33i5.14354

Fakhrzadeh H, Tavakoli J, Amoli M, Mirarefin M, Sharifi F, Ghotbi S, et al. Investigation of the Relation of Methylenetetrahydrofolic Acid MTHFR (C677T) Reduction Gene with Metabolic Syndrome in the Iranian Population: Tehran Homocysteine Study. ijdld. 2009;8(3):289-98.

Kang BS, Ahn DH, Kim NK, Kim JW. Relationship between metabolic syndrome and MTHFR polymorphism in colorectal cancer. J Korean Soc Coloproctol. 2011;27(2):78-82.

https://doi.org/10.3393/jksc.2011.27.2.78

PMid:21602966 PMCid:PMC3092079

Yang B, Fan S, Zhi X, Wang D, Li Y, Wang Y, et al. Associations of MTHFR C677T and MTRR A66G gene polymorphisms with metabolic syndrome: a case-control study in Northern China. Int J Mol Sci. 2014;15(12):21687-702.

https://doi.org/10.3390/ijms151221687

PMid:25429430 PMCid:PMC4284672

Zeman M, Jáachymová M, Jirák R, Vecka M, Tvrzická E, Stankova B, g. Polymorphisms of genes for brain-derived neurotrophic factor, methylenetetrahydrofolate reductase, tyrosine hydroxylase, and endothelial nitric oxide synthase in depression and metabolic syndrome. Folia Biol. 2010;56(1):19.

Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Segawa T, Watanabe S, Ichihara S, Yoshida H, Satoh K, Nozawa Y. Prediction of genetic risk for metabolic syndrome. Atherosclerosis. 2007 Apr 1;191(2):298-304.

https://doi.org/10.1016/j.atherosclerosis.2006.05.035

PMid:16806226

Ellingrod VL, Miller DD, Taylor SF, Moline J, Holman T, Kerr J. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr Res. 2008;98(1):47-54.

https://doi.org/10.1016/j.schres.2007.09.030

PMid:17976958 PMCid:PMC2271139

Gallou-Kabani C, Junien C. Nutritional epigenomics of metabolic syndrome. Diabetes. 2005;54(7):1899-906.

https://doi.org/10.2337/diabetes.54.7.1899

PMid:15983188

Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson B. Epigenetics, disease, and therapeutic interventions. Ageing Res Rev. 2006;5(4):449-67.

https://doi.org/10.1016/j.arr.2006.07.001

PMid:16965942

Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20(1):63-8.

https://doi.org/10.1016/j.nut.2003.09.011

Refbacks

  • There are currently no refbacks.